- Home
- AUPH vs TPB Comparison
AUPH vs TPB Comparison
Compare AUPH & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- TPB
- Stock Information
- Founded
- AUPH 1993
- TPB 1988
- Country
- AUPH Canada
- TPB United States
- Employees
- AUPH N/A
- TPB N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- TPB Tobacco
- Sector
- AUPH Health Care
- TPB Consumer Discretionary
- Exchange
- AUPH Nasdaq
- TPB Nasdaq
- Market Cap
- AUPH 1.1B
- TPB 1.2B
- IPO Year
- AUPH 1999
- TPB 2016
- Fundamental
- Price
- AUPH $8.19
- TPB $76.33
- Analyst Decision
- AUPH Strong Buy
- TPB Strong Buy
- Analyst Count
- AUPH 2
- TPB 4
- Target Price
- AUPH $11.50
- TPB $73.75
- AVG Volume (30 Days)
- AUPH 1.4M
- TPB 212.9K
- Earning Date
- AUPH 07-31-2025
- TPB 07-31-2025
- Dividend Yield
- AUPH N/A
- TPB 0.39%
- EPS Growth
- AUPH N/A
- TPB N/A
- EPS
- AUPH 0.27
- TPB N/A
- Revenue
- AUPH $247,295,000.00
- TPB $384,032,000.00
- Revenue This Year
- AUPH $12.15
- TPB $21.66
- Revenue Next Year
- AUPH $18.31
- TPB $9.08
- P/E Ratio
- AUPH $30.78
- TPB $32.31
- Revenue Growth
- AUPH 29.20
- TPB 24.54
- 52 Week Low
- AUPH $5.15
- TPB $30.62
- 52 Week High
- AUPH $10.67
- TPB $81.05
- Technical
- Relative Strength Index (RSI)
- AUPH 54.75
- TPB 65.15
- Support Level
- AUPH $7.91
- TPB $73.14
- Resistance Level
- AUPH $8.07
- TPB $77.22
- Average True Range (ATR)
- AUPH 0.24
- TPB 1.92
- MACD
- AUPH -0.00
- TPB -0.19
- Stochastic Oscillator
- AUPH 51.85
- TPB 87.01
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in three segments namely Zig-Zag products; Stoker's products and NewGen products. The company generates maximum revenue from the Zig-Zag products segment.